PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS AGENT - ZHEJIANG TRADITIONAL CHINESE MEDICINE RES INST

Title:

PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF ANTI-OSTEOPOROSIS AGENT

Document Type and Number:

Japanese Patent JP2023109691

Kind Code:

A

Abstract:

To provide a pharmaceutical composition that acts as an agent to prevent and treat a drop in blood sugar and diabetic osteoporosis and applications thereof in the preparation of anti-osteoporosis agents.SOLUTION: A pharmaceutical composition comprises 7.64-40.90 wt.% of mangoside (mangiferin), 4.26-7.39 wt.% of tetrahydroepiberberine, 24.33-35.31 wt.% of flavin (phellodendrine), 10.11-14.64 wt.% of Magnoliaceae base (magnoflorine), 2.30-4.26 wt.% of hydroxyoxyberberine (13-hydroxyoxyberberine), 0.12-0.29 wt.% of palmatine, and 17.96-30.71 wt.% of berberine.SELECTED DRAWING: None

Inventors:

WANG NANI
XU PINGCUI
LIN BINGFENG

Application Number:

JP2022176879A

Publication Date:

August 08, 2023

Filing Date:

November 04, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

ZHEJIANG TRADITIONAL CHINESE MEDICINE RES INST

International Classes:

A61K31/4375; A61K31/352; A61K31/473; A61K31/4745; A61P3/10; A61P19/10; A61P43/00

Attorney, Agent or Firm:

Maki Seto

Previous Patent: DEFECT OBSERVATION METHOD, APPARATUS, AND PROGRAM

Next Patent: Media processing device and image forming system